{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:38:40Z","timestamp":1786984720808,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG067618-01"],"award-info":[{"award-number":["R56AG067618-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.archger.2024.105629","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T14:46:04Z","timestamp":1726584364000},"page":"105629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Soumya G.","family":"Chikermane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-901X","authenticated-orcid":false,"given":"Rajender R.","family":"Aparasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archger.2024.105629_bib0005","unstructured":"Alzheimer's Association. 2018 Alzheimer's Disease Facts and Figures. 2018. https:\/\/www.alz.org\/alzheimers-dementia\/facts-figures."},{"issue":"1","key":"10.1016\/j.archger.2024.105629_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: Does it matter?","volume":"36","author":"Andersen","year":"1995","journal-title":"Journal of Health and Social Behavior"},{"key":"10.1016\/j.archger.2024.105629_bib0002","unstructured":"Anon. (ResDAC) RDAC. Available CMS Data. 9 Aug, 2022. https:\/\/resdac.org\/search-data-variables."},{"key":"10.1016\/j.archger.2024.105629_bib0003","unstructured":"Anon. NICE. NICE Real-World Evidence Framework. Accessed 8\/1, 2023. www.nice.org.uk\/corporate\/ecd9\/chapter\/overview."},{"issue":"11","key":"10.1016\/j.archger.2024.105629_bib0004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2174\/1389450116666150518102021","article-title":"Antimuscarinics in the treatment of OAB: Is there a first-line and a second-line choice?","volume":"16","author":"Apostolidis","year":"2015","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.archger.2024.105629_bib0006","doi-asserted-by":"crossref","unstructured":"Boustani M., Campbell N., Munger S., Maidment I., Fox C. Impact of anticholinergics on the aging brain: A review and practical application. 2008.","DOI":"10.2217\/1745509X.4.3.311"},{"issue":"3","key":"10.1016\/j.archger.2024.105629_bib0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: Pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Current Neuropharmacology"},{"issue":"5","key":"10.1016\/j.archger.2024.105629_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjmed.2006.08.036","article-title":"Effective pharmacologic management of Alzheimer's disease","volume":"120","author":"Farlow","year":"2007","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.archger.2024.105629_bib0009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archinte.165.7.808","article-title":"A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs","volume":"165","author":"Gill","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.archger.2024.105629_bib0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00192-011-1411-6","article-title":"Antimuscarinics for the treatment of overactive bladder: Understanding the role of muscarinic subtype selectivity","volume":"22","author":"Glavind","year":"2011","journal-title":"International Urogynecology Journal"},{"issue":"9229","key":"10.1016\/j.archger.2024.105629_bib0011","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(00)02588-5","article-title":"Urinary incontinence: An unrecognised adverse effect with donepezil","volume":"356","author":"Hashimoto","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"19","key":"10.1016\/j.archger.2024.105629_bib0012","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.archger.2024.105629_bib0013","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s11606-020-05634-3","article-title":"Risk of mortality associated with non-selective antimuscarinic medications in older adults with dementia: a retrospective study","volume":"35","author":"Kachru","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"7512","key":"10.1016\/j.archger.2024.105629_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.331.7512.321","article-title":"Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials","volume":"331","author":"Kaduszkiewicz","year":"2005","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.archger.2024.105629_bib0015","first-page":"H369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ (Clinical research ed.)"},{"issue":"8","key":"10.1016\/j.archger.2024.105629_bib0016","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/gerona\/gly197","article-title":"Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study","volume":"74","author":"Kim","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.archger.2024.105629_bib0017","first-page":"1","article-title":"Dementia mortality in the United States, 2000-2017","volume":"68","author":"Kramarow","year":"2019","journal-title":"National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System"},{"issue":"7","key":"10.1016\/j.archger.2024.105629_bib0018","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/jgs.14220","article-title":"Use of cholinesterase inhibitors increases initiation of urinary anticholinergics in persons with Alzheimer's disease","volume":"64","author":"Lampela","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"issue":"3","key":"10.1016\/j.archger.2024.105629_bib0019","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.archger.2024.105629_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2014.11.018","article-title":"Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment","volume":"96","author":"Lombardo","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.archger.2024.105629_bib0021","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jgs.17579","article-title":"Risk of overactive bladder associated with cholinesterase inhibitors in dementia","volume":"70","author":"Masurkar","year":"2022","journal-title":"Journal of the American Geriatrics Society"},{"issue":"7","key":"10.1016\/j.archger.2024.105629_bib0022","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ Elixhauser comorbidity index","volume":"55","author":"Moore","year":"2017","journal-title":"Medical Care"},{"key":"10.1016\/j.archger.2024.105629_bib0023","first-page":"1457","article-title":"Potential drug-drug interactions in Alzheimer patients with behavioral symptoms","volume":"10","author":"Pasqualetti","year":"2015","journal-title":"Clinical Interventions In Aging"},{"issue":"12","key":"10.1016\/j.archger.2024.105629_bib0024","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1136\/oem.2004.014472","article-title":"An incidence density sampling program for nested case-control analyses","volume":"61","author":"Richardson","year":"2004","journal-title":"Occupational and Environmental Medicine"},{"issue":"10081","key":"10.1016\/j.archger.2024.105629_bib0025","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","article-title":"The prescribing cascade revisited","volume":"389","author":"Rochon","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.archger.2024.105629_bib0026","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1532-5415.2008.01681.x","article-title":"Dual use of bladder anticholinergics and cholinesterase inhibitors: Long-term functional and cognitive outcomes","volume":"56","author":"Sink","year":"2008","journal-title":"Journal of the American Geriatrics Society"},{"issue":"2","key":"10.1016\/j.archger.2024.105629_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jalz.2010.03.016","article-title":"Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease","volume":"7","author":"Small","year":"2011","journal-title":"Alzheimer's & dementia : the journal of the Alzheimer's Association"},{"issue":"4","key":"10.1016\/j.archger.2024.105629_bib0028","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.archger.2024.105629_bib0029","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324003054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324003054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T16:49:53Z","timestamp":1730393393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494324003054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"alternative-id":["S0167494324003054"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2024.105629","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2024.105629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105629"}}